Evidence map›Paper›PMID 23619897›Full record

ArticleMolecular imaging and biology2013

Tumor margin detection using quantitative NIRF molecular imaging targeting EpCAM validated by far red gene reporter iRFP.

Banghe Zhu, Grace Wu, Holly Robinson, Nathaniel Wilganowski, Mary A Hall, Sukhen C Ghosh, Kenneth L Pinkston, Ali Azhdarinia, Barrett R Harvey, Eva M Sevick-Muraca

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular imaging and biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Fluorescently Labeled Cetuximab-IRDye800 for Guided Surgical Excision of Ameloblastoma: A Proof of Principle Study.Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons · 2020
    Article
  6. Article
  7. Protease-Activatable Adeno-Associated Virus Vector for Gene Delivery to Damaged Heart Tissue.Molecular therapy : the journal of the American Society of Gene Therapy · 2019
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Banghe ZhuCenter for Molecular Imaging, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center, 1825 Pressler Street, Houston, TX, 77030, USA.
Grace Wu
Holly Robinson
Nathaniel Wilganowski
Mary A Hall
Sukhen C Ghosh
Kenneth L Pinkston
Ali Azhdarinia
Barrett R Harvey
Eva M Sevick-Muraca
The University of Texas Health Science Center at Houston · USBrown Foundation · US

Funding

Task Specific Project 4U54CA136404 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SEVICK, EVA M. · 2008 to 2012
$5.1M
NCI NIH HHS U54 CA136404
6 · The paper itself

Abstract

purposeWide-field surgical excision reduces the chance of residual disease, but can also lead to disfigurement and devastating morbidities when resection is close to critical structures. We hypothesize that near-infrared fluorescence (NIRF) imaging can enable accurate detection of tumor margins for image-guided resection. EXPERIMENTAL

designAn orthotopic model of human prostate cancer (PCa) was used to assess primary tumor margins using a NIRF-labeled antibody against epithelial cell adhesion molecule (EpCAM). PCa cells stably expressing far red fluorescent gene reporter, iRFP, enabled colocalization with NIRF signals for direct assessment of tumor margins.

resultsUsing receiver operating characteristic analysis, far red fluorescence was validated against standard pathology of primary and metastatic lesions with >96 % accuracy. Primary tumor margins were more accurately detected by quantitative NIRF imaging using the EpCAM-targeting antibody as compared to a NIRF-labeled isotype control antibody.

conclusionsNIRF molecular imaging may enable real-time and accurate assessment of tumor margins.

Indexed as

Genes, ReporterSpectroscopy, Near-InfraredAnimalsAntigens, NeoplasmBenzenesulfonatesCell Adhesion MoleculesCell Line, TumorDisease ProgressionEpithelial Cell Adhesion MoleculeHumansIndolesLuminescent ProteinsLymph NodesMaleMiceMolecular ImagingAntigens, NeoplasmBenzenesulfonatesCell Adhesion MoleculesEpithelial Cell Adhesion MoleculeIndolesIRDye 800CWLuminescent ProteinsRed Fluorescent Protein

Identifiers

PMID23619897
OpenAlexW2040400599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.